Revenue |
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Revenue from Contract with Customer [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Revenue | 3. Revenue Revenue by geographic region is based on the country in which our customer is domiciled and is summarized by geographic area as follows (in thousands):
There is currently no revenue generated in the United States from sales of the Allurion Smart Capsule. For the year ended December 31, 2025, $4.7 million of revenue was generated in five countries included within All other countries in the table above, representing approximately 31% of Total Revenues, with each country responsible for approximately 4%-9% of the total. The remaining revenue was generated by sales in 44 other countries included within All other countries. For the year ended December 31, 2024, $10.3 million of revenue was generated in five countries included within All other countries, representing approximately 32% of Total Revenues, with each country responsible for approximately 4%-8% of the total. Remaining revenue was generated by sales in 53 other countries included within All other countries. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||